158 related articles for article (PubMed ID: 38294704)
1. Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years.
D'Souza G; Tewari SR; Troy T; Webster-Cyriaque J; Wiley DJ; Lahiri CD; Palella FJ; Gillison ML; Strickler HD; Struijk L; Waterboer T; Ho K; Kwait J; Lazar J; Weber KM; Fakhry C
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):516-524. PubMed ID: 38294704
[TBL] [Abstract][Full Text] [Related]
2. Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.
Kreimer AR; Pierce Campbell CM; Lin HY; Fulp W; Papenfuss MR; Abrahamsen M; Hildesheim A; Villa LL; Salmerón JJ; Lazcano-Ponce E; Giuliano AR
Lancet; 2013 Sep; 382(9895):877-87. PubMed ID: 23827089
[TBL] [Abstract][Full Text] [Related]
3. Risk factors for acquisition and clearance of oral human papillomavirus infection among HIV-infected and HIV-uninfected adults.
Beachler DC; Sugar EA; Margolick JB; Weber KM; Strickler HD; Wiley DJ; Cranston RD; Burk RD; Minkoff H; Reddy S; Xiao W; Guo Y; Gillison ML; D'Souza G
Am J Epidemiol; 2015 Jan; 181(1):40-53. PubMed ID: 25480823
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the Utility and Prevalence of HPV Biomarkers in Oral Rinses and Serology for HPV-related Oropharyngeal Cancer.
D'Souza G; Clemens G; Troy T; Castillo RG; Struijk L; Waterboer T; Bender N; Pierorazio PM; Best SR; Strickler H; Wiley DJ; Haddad RI; Posner M; Fakhry C
Cancer Prev Res (Phila); 2019 Oct; 12(10):689-700. PubMed ID: 31420362
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistence of oral human papillomavirus type 16: the HPV Infection in Men (HIM) study.
Pierce Campbell CM; Kreimer AR; Lin HY; Fulp W; O'Keefe MT; Ingles DJ; Abrahamsen M; Villa LL; Lazcano-Ponce E; Giuliano AR
Cancer Prev Res (Phila); 2015 Mar; 8(3):190-6. PubMed ID: 25575501
[TBL] [Abstract][Full Text] [Related]
6. Understanding personal risk of oropharyngeal cancer: risk-groups for oncogenic oral HPV infection and oropharyngeal cancer.
D'Souza G; McNeel TS; Fakhry C
Ann Oncol; 2017 Dec; 28(12):3065-3069. PubMed ID: 29059337
[TBL] [Abstract][Full Text] [Related]
7. Association of cervical precancer with human papillomavirus types other than 16 among HIV co-infected women.
Massad LS; Xie X; Burk RD; D'Souza G; Darragh TM; Minkoff H; Colie C; Burian P; Palefsky J; Atrio J; Strickler HD
Am J Obstet Gynecol; 2016 Mar; 214(3):354.e1-6. PubMed ID: 26433170
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults.
Beachler DC; Weber KM; Margolick JB; Strickler HD; Cranston RD; Burk RD; Wiley DJ; Minkoff H; Reddy S; Stammer EE; Gillison ML; D'Souza G
Cancer Epidemiol Biomarkers Prev; 2012 Jan; 21(1):122-33. PubMed ID: 22045700
[TBL] [Abstract][Full Text] [Related]
9. The association of medication use with clearance or persistence of oral HPV infection.
Lam JO; Sugar EA; Cranston RD; Weber KM; Burk RD; Wiley DJ; Reddy S; Margolick JB; Strickler HD; Wentz A; Jacobson L; Coles CL; Bream JH; Rositch AF; Guo Y; Xiao W; Gillison ML; D'Souza G
Cancer Causes Control; 2016 Dec; 27(12):1491-1498. PubMed ID: 27804058
[TBL] [Abstract][Full Text] [Related]
10. Twelve-month incidence and clearance of oral HPV infection in HIV-negative and HIV-infected men who have sex with men: the H2M cohort study.
van Aar F; Mooij SH; van der Sande MA; Meijer CJ; King AJ; Verhagen DW; Heijman T; Coutinho RA; Schim van der Loeff MF
BMC Infect Dis; 2014 Dec; 14():668. PubMed ID: 25551194
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of oral and blood oncogenic human papillomavirus biomarkers among an enriched screening population: Baseline results of the MOUTH study.
D'Souza G; Tewari SR; Troy T; Waterboer T; Struijk L; Castillo R; Wright H; Shen M; Miles B; Johansson M; Robbins HA; Fakhry C
Cancer; 2023 Aug; 129(15):2373-2384. PubMed ID: 37032449
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Implication of Persistent Human Papillomavirus Type 16 DNA Detection in Oral Rinses for Human Papillomavirus-Related Oropharyngeal Carcinoma.
Rettig EM; Wentz A; Posner MR; Gross ND; Haddad RI; Gillison ML; Fakhry C; Quon H; Sikora AG; Stott WJ; Lorch JH; Gourin CG; Guo Y; Xiao W; Miles BA; Richmon JD; Andersen PE; Misiukiewicz KJ; Chung CH; Gerber JE; Rajan SD; D'Souza G
JAMA Oncol; 2015 Oct; 1(7):907-15. PubMed ID: 26226294
[TBL] [Abstract][Full Text] [Related]
13. Long-term Persistence of Oral HPV Over 7 Years of Follow-up.
D'Souza G; Clemens G; Strickler HD; Wiley DJ; Troy T; Struijk L; Gillison M; Fakhry C
JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa047. PubMed ID: 33225205
[TBL] [Abstract][Full Text] [Related]
14. Factors Associated With Persistence and Clearance of High-Risk Oral Human Papillomavirus (HPV) Among Participants in the HPV Infection in Men (HIM) Study.
Bettampadi D; Sirak BA; Abrahamsen ME; Reich RR; Villa LL; Ponce EL; Giuliano AR
Clin Infect Dis; 2021 Nov; 73(9):e3227-e3234. PubMed ID: 33173937
[TBL] [Abstract][Full Text] [Related]
15. Risk Factors for Oral Human Papillomavirus Infection Among Young Men Who Have Sex With Men-2 Cities, United States, 2012-2014.
Oliver SE; Gorbach PM; Gratzer B; Steinau M; Collins T; Parrish A; Kerndt PR; Crosby RA; Unger ER; Markowitz LE; Meites E
Sex Transm Dis; 2018 Oct; 45(10):660-665. PubMed ID: 30204745
[TBL] [Abstract][Full Text] [Related]
16. Screening for HPV-related oropharyngeal, anal, and penile cancers in middle-aged men: Initial report from the HOUSTON clinical trial.
Dahlstrom KR; Anderson KS; Guo M; Kwon MC; Messick CA; Pettaway CA; Asomaning N; Hopper M; Price A; Xu L; Day AT; Gillenwater AM; Sturgis EM
Oral Oncol; 2021 Sep; 120():105397. PubMed ID: 34182223
[TBL] [Abstract][Full Text] [Related]
17. A longitudinal study of human papillomavirus 16 L1, e6, and e7 seropositivity and oral human papillomavirus 16 infection.
Beachler DC; Viscidi R; Sugar EA; Minkoff H; Strickler HD; Cranston RD; Wiley DJ; Jacobson LP; Weber KM; Margolick JB; Reddy S; Gillison ML; D'Souza G
Sex Transm Dis; 2015 Feb; 42(2):93-7. PubMed ID: 25585068
[TBL] [Abstract][Full Text] [Related]
18. Cervical Precancer Risk in HIV-Infected Women Who Test Positive for Oncogenic Human Papillomavirus Despite a Normal Pap Test.
Keller MJ; Burk RD; Massad LS; Eltoum IE; Hessol NA; Castle PE; Anastos K; Xie X; Minkoff H; Xue X; D'Souza G; Flowers L; Levine AM; Colie C; Rahangdale L; Fischl MA; Palefsky JM; Strickler HD
Clin Infect Dis; 2015 Nov; 61(10):1573-81. PubMed ID: 26187020
[TBL] [Abstract][Full Text] [Related]
19. Primary HPV and Molecular Cervical Cancer Screening in US Women Living With Human Immunodeficiency Virus.
Strickler HD; Keller MJ; Hessol NA; Eltoum IE; Einstein MH; Castle PE; Massad LS; Flowers L; Rahangdale L; Atrio JM; Ramirez C; Minkoff H; Adimora AA; Ofotokun I; Colie C; Huchko MJ; Fischl M; Wright R; D'Souza G; Leider J; Diaz O; Sanchez-Keeland L; Shrestha S; Xie X; Xue X; Anastos K; Palefsky JM; Burk RD
Clin Infect Dis; 2021 May; 72(9):1529-1537. PubMed ID: 32881999
[TBL] [Abstract][Full Text] [Related]
20. Rates and determinants of oral human papillomavirus infection in young men.
Edelstein ZR; Schwartz SM; Hawes S; Hughes JP; Feng Q; Stern ME; O'Reilly S; Lee SK; Fu Xi L; Koutsky LA
Sex Transm Dis; 2012 Nov; 39(11):860-7. PubMed ID: 23064535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
